A 3-Week, Open Label Study to Evaluate The Efficacy and Safety of Extended Release Quetiapine Fumarate in The Treatment of Agitation in Patients with Schizophrenia.

JS, Gill (2013) A 3-Week, Open Label Study to Evaluate The Efficacy and Safety of Extended Release Quetiapine Fumarate in The Treatment of Agitation in Patients with Schizophrenia. pp. 14-23.

[img] PDF
psiko 2013.pdf

Download (722kB)

Abstract

-

Item Type: Article
Uncontrolled Keywords: A 3-Week, Open Label Study to Evaluate The Efficacy and Safety of Extended Release Quetiapine Fumar
Subjects: R Medicine
Depositing User: MR. ADNAN YAHYA
Date Deposited: 30 Apr 2013
Last Modified: 30 Apr 2013
URI: http://repository.um.edu.my/id/eprint/29309

Actions (login required)

View Item View Item